{"title":"基于人群的全因过敏性休克发病率及其随时间的发展:系统回顾和荟萃分析。","authors":"Vanessa Pühringer, Bernd Jilma, Harald Herkner","doi":"10.3389/falgy.2023.1249280","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>It is extremely difficult to compare studies investigating the frequency of anaphylaxis making it challenging to satisfactorily assess the worldwide incidence rate. Using a systematic review and meta-analysis, this publication aims to determine the current incidence of all-cause anaphylaxis worldwide. Additionally, we investigated whether the incidence of anaphylaxis has changed over time and which factors influence the rates determined by individual studies.</p><p><strong>Methods: </strong>A literature search was performed in four databases. All articles that reported relevant information on population-based incidence rates of all-cause anaphylaxis were included. The protocol was published on INPLASY, the International Platform of Registered Systematic Review and Meta-analysis Protocols.</p><p><strong>Results: </strong>The database query and screening process resulted in 46 eligible articles on anaphylaxis. The current incidence worldwide was found to be approximately 46 cases per 100,000 population per year (95% CI 21-103). Evaluating confounding factors showed that studies using allergy clinics and hospitalizations as data source result in comparably low rates. Moreover, children are less prone to develop anaphylaxis compared to the general population. Using a random effects Poisson model we calculated a yearly increase of anaphylaxis incidence by 7.4% (95% CI 7.3-7.6, <i>p</i> < 0.05).</p><p><strong>Discussion: </strong>This seems to be the first approach to analyze every reported all-cause anaphylaxis incidence rate until 2017 for an at most accurate determination of its epidemiology. Based on these results, future research could investigate the underlying causes for the rising incidence in order find ways to decrease the condition's frequency.</p><p><strong>Systematic review registration: </strong>inplasy.com, identifier [INPLASY202330047].</p>","PeriodicalId":73062,"journal":{"name":"Frontiers in allergy","volume":"4 ","pages":"1249280"},"PeriodicalIF":3.3000,"publicationDate":"2023-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10749935/pdf/","citationCount":"0","resultStr":"{\"title\":\"Population-based incidence of all-cause anaphylaxis and its development over time: a systematic review and meta-analysis.\",\"authors\":\"Vanessa Pühringer, Bernd Jilma, Harald Herkner\",\"doi\":\"10.3389/falgy.2023.1249280\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>It is extremely difficult to compare studies investigating the frequency of anaphylaxis making it challenging to satisfactorily assess the worldwide incidence rate. Using a systematic review and meta-analysis, this publication aims to determine the current incidence of all-cause anaphylaxis worldwide. Additionally, we investigated whether the incidence of anaphylaxis has changed over time and which factors influence the rates determined by individual studies.</p><p><strong>Methods: </strong>A literature search was performed in four databases. All articles that reported relevant information on population-based incidence rates of all-cause anaphylaxis were included. The protocol was published on INPLASY, the International Platform of Registered Systematic Review and Meta-analysis Protocols.</p><p><strong>Results: </strong>The database query and screening process resulted in 46 eligible articles on anaphylaxis. The current incidence worldwide was found to be approximately 46 cases per 100,000 population per year (95% CI 21-103). Evaluating confounding factors showed that studies using allergy clinics and hospitalizations as data source result in comparably low rates. Moreover, children are less prone to develop anaphylaxis compared to the general population. Using a random effects Poisson model we calculated a yearly increase of anaphylaxis incidence by 7.4% (95% CI 7.3-7.6, <i>p</i> < 0.05).</p><p><strong>Discussion: </strong>This seems to be the first approach to analyze every reported all-cause anaphylaxis incidence rate until 2017 for an at most accurate determination of its epidemiology. Based on these results, future research could investigate the underlying causes for the rising incidence in order find ways to decrease the condition's frequency.</p><p><strong>Systematic review registration: </strong>inplasy.com, identifier [INPLASY202330047].</p>\",\"PeriodicalId\":73062,\"journal\":{\"name\":\"Frontiers in allergy\",\"volume\":\"4 \",\"pages\":\"1249280\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2023-12-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10749935/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in allergy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3389/falgy.2023.1249280\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"ALLERGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in allergy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/falgy.2023.1249280","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0
摘要
导言:对过敏性休克发生频率的调查研究进行比较非常困难,因此很难令人满意地评估全球发病率。通过系统回顾和荟萃分析,本出版物旨在确定目前全球各种原因过敏性休克的发病率。此外,我们还调查了过敏性休克的发病率是否随着时间的推移而变化,以及哪些因素会影响个别研究确定的发病率:方法:我们在四个数据库中进行了文献检索。方法:我们在四个数据库中进行了文献检索,纳入了所有报道基于人群的全因过敏性休克发病率相关信息的文章。研究方案发布在 INPLASY(注册系统综述和荟萃分析方案国际平台)上:通过数据库查询和筛选,共有 46 篇符合条件的关于过敏性休克的文章。发现目前全球的发病率约为每年每 10 万人 46 例(95% CI 21-103)。对混杂因素的评估显示,使用过敏诊所和住院治疗作为数据来源的研究结果显示,过敏性休克的发病率相对较低。此外,与普通人群相比,儿童更不容易发生过敏性休克。利用随机效应泊松模型,我们计算出过敏性休克发病率每年增加 7.4%(95% CI 7.3-7.6,p 讨论):这似乎是第一种分析 2017 年之前报告的所有原因过敏性休克发病率的方法,以便最准确地确定其流行病学。基于这些结果,未来的研究可以调查发病率上升的根本原因,从而找到降低该病发病率的方法。系统综述注册:inplasy.com,标识符[INPLASY202330047]。
Population-based incidence of all-cause anaphylaxis and its development over time: a systematic review and meta-analysis.
Introduction: It is extremely difficult to compare studies investigating the frequency of anaphylaxis making it challenging to satisfactorily assess the worldwide incidence rate. Using a systematic review and meta-analysis, this publication aims to determine the current incidence of all-cause anaphylaxis worldwide. Additionally, we investigated whether the incidence of anaphylaxis has changed over time and which factors influence the rates determined by individual studies.
Methods: A literature search was performed in four databases. All articles that reported relevant information on population-based incidence rates of all-cause anaphylaxis were included. The protocol was published on INPLASY, the International Platform of Registered Systematic Review and Meta-analysis Protocols.
Results: The database query and screening process resulted in 46 eligible articles on anaphylaxis. The current incidence worldwide was found to be approximately 46 cases per 100,000 population per year (95% CI 21-103). Evaluating confounding factors showed that studies using allergy clinics and hospitalizations as data source result in comparably low rates. Moreover, children are less prone to develop anaphylaxis compared to the general population. Using a random effects Poisson model we calculated a yearly increase of anaphylaxis incidence by 7.4% (95% CI 7.3-7.6, p < 0.05).
Discussion: This seems to be the first approach to analyze every reported all-cause anaphylaxis incidence rate until 2017 for an at most accurate determination of its epidemiology. Based on these results, future research could investigate the underlying causes for the rising incidence in order find ways to decrease the condition's frequency.